fda drug shortages semaglutide injection resolved date 2025 📢 has determined the shortage of products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the The weight loss drug shortage

Some patients experience gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation when they start semaglutide, even if they tolerated tirzepatide

Cardiovascular Protection GLP-1 receptor agonists are also known to reduce the risk of cardiovascular events, such as heart attacks and strokes, which are prevalent among older adults

Frequently Asked Questions How quickly will I see weight loss on the scale after my first semaglutide injection

The future of GLP-1 therapy seems promising, with several significant advancements anticipated

The injured Illinoisans case joins nearly 60 others alleging that Ozempic and Wegovy, another Novo Nordisk product, caused stomach paralysis among other debilitating conditions and side effects

Eating small and frequent meals, staying hydrated, eating well-balanced meals, and sticking to the suggested medicine dosage can all help with symptom management